To facilitate discussion, this paper describes various types of collections of specimens, their
uses in research, types of identifiers, requirements for informed consent, third-party access …

Purpose: On 11 and 12 June 2012, the National Cancer Institute hosted a think tank
concerning the identifiability of biospecimens and “omic” data in order to explore challenges …

Recent advances in molecular pathology and molecular genetics have created new
concerns about the use of human biologic materials in research. Since researchers now …

Increasingly, genetic and biomedical researchers are developing protocols to reexamine
human tissue specimens that were obtained and stored during clinical care or previous …

Although issues associated with returning individual research results to study participants
have been well explored, these issues have been less thoroughly investigated in vulnerable …

Background Recent changes to regulatory guidance in the US and Europe have
complicated oversight of secondary research by rendering most uses of de-identified data …

Background: The practice of biorepository-based genetics research raises questions related
to what ethical obligations researchers have to their participants. It is important to explore …

The National Bioethics Advisory Commission (NBAC) estimates that there are over 282
million human biologic specimens being stored in the United States, and that this number is …

Background: The debate about returning research results has revealed different
perspectives among researchers, participants and advisory groups with participants …

Genetic research increasingly focuses on population-specific human genetic diversity.
However, the naming of a human population in public databases and scientific publications …